Patent · US Active

Crystalline dipeptides useful in the synthesis of elamipretide

US11560404B2 · kind B2 · utility

1Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2021
Grant dateJan 24, 2023
Priority date—
Expiry dateApr 7, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH2 and Boc-D-Arg-DMT. The crystalline forms may be used in the synthesis of elamipretide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.